Advantages and limitations of particle-mediated transfection (gene gun) in cancer immuno-gene therapy using IL-10, IL-12 or B7-1 in murine tumor models

Journal of Gene Medicine

Volumn 5, Issue 11, 2003, Pages 958-965

  Kitagawa, Toru ^a   Iwazawa, Takashi ^a   Robbins, Paul D ^a   Lotze, Michael T ^a   Tahara, Hideaki ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

B7 1; Gene gun; Gene therapy; IL 10; IL 12

Indexed keywords

B7 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; LIPOSOME; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FIBROSARCOMA; FLOW CYTOMETRY; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR CELL CULTURE; TUMOR VOLUME; ANALYSIS OF VARIANCE; ANIMAL; BIOLISTIC TRANSFORMATION; COMPARATIVE STUDY; CYTOMEGALOVIRUS; GENE EXPRESSION REGULATION; GENE THERAPY; GENE VECTOR; GENETICS; METABOLISM; METHODOLOGY; NEOPLASM; TUMOR CELL LINE;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD80; BIOLISTICS; CELL LINE, TUMOR; CYTOKINES; CYTOMEGALOVIRUS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENETIC VECTORS; INTERLEUKIN-10; INTERLEUKIN-12; MICE; NEOPLASMS; TRANSFECTION;

EID: 3242704358     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.441     Document Type: Article

References (38)

1. Yang NS, Burkholder J, Roberts B, et al. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Natl Acad Sci U S A 1990; 87: 9568-9572.
2. Williams RS, Johnston SA, Riedy M, et al. Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. Proc Natl Acad Sci U S A 1991; 88: 2726-2730.
3. Thompson TA, Gould MN, Burkholder JK, et al. Transient promoter activity in primary rat mammary epithelial cells evaluated using particle bombardment gene transfer. In Vitro Cell Dev Biol 1993; 29A: 165-170.
4. Yang NS, Sun WH. Gene gun and other non-viral approaches for cancer gene therapy. Nat Med 1995; 1: 481-483.
5. Rakhmilevich AL, Turner J, Ford MJ, et al. Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors. Proc Natl Acad Sci U S A 1996; 93: 6291-6296.
6. Mahvi DM, Burkholder JK, Turner J, et al. Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: implications for a clinically relevant tumor vaccine. Hum Gene Ther 1996; 7: 1535-1543.
7. Mahvi DM, Sondel PM, Yang NS, et al. Phase I/IB study of immunization with autologous tumor cells transfected with the GM-CSF gene by particle-mediated transfer in patients with melanoma or sarcoma. Hum Gene Ther 1997; 8: 875-891.
8. Brunda MJ, Luistro L, Warrier RR, et al. Antitumor and antimetastatic activity of interleukin-12 against murine tumors. J Exp Med 1993; 178: 1223-1230.
9. Berman RM, Suzuki T, Tahara H, et al. Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice. J Immunol 1996; 157: 231-238.
10. Suzuki T, Tahara H, Narula S, et al. Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors. J Exp Med 1995; 182: 477-486.
11. Kobayashi M, Fitz L, Ryan M, et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989; 170: 827-845.
12. Naume B, Gately M, Espevik T. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2- and IL-7-induced effects on immunomagnetically purified CD56+ NK cells. J Immunol 1992; 148: 2429-2436.
13. Cui J, Shin T, Kawano T, et al. Requirement for Vα 14 NKT cells in IL-12-mediated rejection of tumors. Science 1997; 278: 1623-1626.
14. Gately MK, Desai BB, Wolitzky AG, et al. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol 1991; 147 874-882.
15. Hsieh CS, Macatonia S, Tripp C, et al. Development of Th1 CD4+ T cells through IL-12 produced by listeria-induced macrophages. Science 1993; 260: 547-549.
16. Voest EE, Kenyon BM, O'Reilly MS, et al. Inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Inst 1995; 87: 581-586.
17. Sgadari C, Angiolillo AL, Tosato G. Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10. Blood 1996; 87: 3877-3882.
18. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secret a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081-2095.
19. de Waal Malefyt R, Haanen J, Spits H, et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991; 174: 915-924.
20. Ding L, Linsley PS, Huang LY, et al. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993; 151: 1224-1234.
21. Chen WF, Zlotnik A. IL-10: a novel cytotoxic T cell differentiation factor. J Immunol 1991; 147: 528-534.
22. Jinquan T, Larsen CG, Gesser B, et al. Human IL-10 is a chemoattractant for CD8+ T lymphocytes and an inhibitor of IL-8-induced CD4+ T lymphocyte migration. J Immunol 1993; 151: 4545-4551.
23. Schwarz MA, Hamilton LD, Tardelli L, et al. Stimulation of cytolytic activity by interleukin-10. J Immunother 1994; 16 95-104.
24. Carson WE, Lindemann MJ, Baiocchi R, et al. The functional characterization of interleukin-10 receptor expression on human natural killer cells. Blood 1995; 85: 3577-3585.
25. Qian S, Li W, Li Y, et al. Systemic administration of cellular interleukin-10 can exacerbate cardiac allograft rejection in mice. Transplantation 1996; 62: 1709-1714.
26. Ghattas IR, Sanes JR, Majors JE. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol Cell Biol 1991; 11: 5848-5859.
27. Rakhmilevich AL, Janssen K, Turner J, et al. Cytokine gene therapy of cancer using gene gun technology: superior antitumor activity of interleukin-12. Hum Gene Ther 1997; 8: 1303-1311.
28. Tahara H, Zitvogel L, Storkus WJ, et al. Effective eradication of established murine tumors with interleukin 12 (IL-12) gene therapy using a polycistronic retroviral vector. J Immunol 1995; 154: 6466-6474.
29. Chen L, Ashe S, Brady WA, et al. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 1992; 71: 1093-1102.
30. Townsend SE, Allison JP. Tumor rejection after direct costimulation of CD8+ cells by B7-transfected melanoma cells. Science 1993; 259: 368-370.
31. Kubin M, Kamoun M, Trinchieri G. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J Exp Med 1994; 180: 211-222.
32. Murphy EE, Terres G, Macatonia SE, et al. B7 and interleukin 12 cooperate for proliferation and interferon-γ production by mouse T helper clones that are unresponsive to B7 costimulation. J Exp Med 1994; 180: 223-231.
33. Zitvogel L, Robbins PD, Storkus WJ, et al. Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors. Eur J Immunol 1996; 26: 1335-1341.
34. Li Y, McGowan P, Hellstrom I, et al. Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma. J Immunol 1994; 153: 421-428.
35. Fallarino F, Ashikari A, Boon T, et al. Antigen-specific regression of established tumors induced by active immunization with irradiated IL-12- but not B7-1-transfected tumor cells. Int Immunol 1997; 9: 1259-1269.
36. Richter G, Kruger-Krasagakes S, Hein G, et al. Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res 1993; 53 4134-4137.
37. Nastala CL, Edington HD, McKinney TG, et al. Recombinant interleukin-12 administration induces tumor regression in association with interferon-gamma and nitric oxide production. J Immunol 1994; 153: 1697-1706.
38. Li W, Lu L, Li Y, et al. High-dose cellular IL-10 exacerbates rejection and reverses effects of cyclosporine and tacrolimus in mouse cardiac transplantation. Transplant Proc 1997; 29: 1081-1082.